Alison Walsh

Senior Scientist at TCR2 Therapeutics - Cambridge, MA, US

Alison Walsh's Contact Details
HQ
617-949-5200
Location
Boston, Massachusetts, United States
Company
TCR2 Therapeutics
Alison Walsh's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Alison Walsh
Alison Walsh currently works for TCR2 Therapeutics.
Alison Walsh's role at TCR2 Therapeutics is Senior Scientist.
Alison Walsh's email address is ***@tcr2.com. To view Alison Walsh's full email address, please signup to ConnectPlex.
Alison Walsh works in the BioTech/Drugs industry.
Alison Walsh's colleagues at TCR2 Therapeutics are Sudarshana Sengupta, Dana Gilmore, Urmi Patankar, Chris Manoogian, Stephanie Martin, Breckon Bauer, Richard Decker and others.
Alison Walsh's phone number is 617-949-5200
See more information about Alison Walsh